On the verge of demonstrating to the world Looks like TLT's strategy will be to throw a bone to many starving dogs with the ultimate goal to have the strongest one reap all of the other bones.
Roger is a fierce negotiator.
" I look forward to assisting Theralase® achieve its strategic objectives of commercialization through partnering of its lead pharmaceutical drug with large pharmaceutical organizations in North America and internationally. Theralase® is at an inflection point in its drug development pipeline and I believe this highly promising Canadian-born Anti-Cancer Therapy ("ACT") is on the verge of demonstrating to the world the safety and efficacy that this platform truly bring to patients inflicted with cancer; firstly for patients diagnosed with Bacillus Calmette-Gurin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC"), who are running out of therapeutic options and are facing bladder removal surgery.""